Kimia Biosciences Share price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,782 shares, with a market capitalization of ₹47312741. Its Average Traded Price (ATP) is ₹28.56, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 236 @ ₹28.50.
Kimia Biosciences has an upper circuit limit of ₹34.20 and a lower circuit limit of ₹22.80. The total value traded stands at ₹50893.92, and the delivery percentage for the day is 100%.
The stock is currently traded with a market lot size of 1. Kimia Biosciences also offers a dividend yield of 0%.
Kimia Biosciences share price chart
Kimia Biosciences Share Key Metrics
Volume
1782.00
Market Cap
134.84 CR
LTQ@LTP
236@28.50
ATP
28.56
Var Margin
29.07 %
Circuit Range
22.8-34.2
Delivery %
100 %
Value
50893.92
ASM/GSM
No
Market Lot
1
Kimia Biosciences Resistance and Support
Pivot 28.4
Resistance
First Resistance
28.81
Second Resistance
29.11
Third Resistance
29.52
Support
First Support
28.1
Second Support
27.69
Third Support
27.39
Kimia Biosciences Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Kimia Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2026-02-14 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-09-04 | Final Dividend & A.G.M. |
| 2025-08-29 | A.G.M. & Others |
| 2025-08-14 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-05-05 | Others |
| 2025-04-23 | Others |
| 2025-02-13 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Kimia Biosciences News
Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 10, 2026 (Monday)
Kimia Biosciences' board approved Q1 FY27 standalone financial results. Revenue from operations for the quarter ended June 30, 2026, stood at ₹20.72 crore, a 12.1% decrease YoY, while net profit declined 41.1% YoY to ₹0.36 crore.
Aug 10 2026 16:52:54
Kimia Biosciences Ltd - 530313 - Board Meeting Intimation for Regulation 29 Of SEBI (LODR) Regulations, 2015 -Intimation Of Meeting Of Board Of Directors.
Kimia Biosciences' Board of Directors is scheduled to meet on August 10, 2026. The primary agenda includes considering and approving the unaudited financial results for the first quarter ended June 30, 2026.
Aug 03 2026 15:58:18
Kimia Biosciences Ltd - 530313 - Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Held On August 1, 2026 Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Kimia Biosciences Board of Directors met on August 1, 2026, and approved the appointment of M/s Mahesh Singh & Co. as Cost Auditor and M/s Chaudhry & Associates as Internal Auditor for FY 2026-27. The board also discontinued M/s M & Co. and appointed M/s Maya Sharma and Associates as Secretarial Auditor for FY 2025-27 and FY 2026-27.
Aug 01 2026 23:13:36
Kimia Biosciences Management
| Name | Position |
|---|---|
| Sameer Goel | Chairman & Managing Director |
| Abhishek Kumar Pandey | Company Secretary & Compliance Officer |
Kimia Biosciences FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in KIMIABL
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
+ Free 1st Year AMC